Sirtex appoints new CEO
Thursday, 26 May, 2005
Sydney biomedical company Sirtex Medical (ASX:SRX) has promoted Gilman Wong from chief operating officer to chief executive officer.
Wong only joined Sirtex in February 2005 but chairman Bruce Gray said that he "has made a substantial contribution to company activities since then."
Wong has a strong background in sales and marketing -- a potentially useful background for Sirtex, whose sales revenue last year grew 8 per cent to $4.9 million, but whose gross profit fell to $3.57 million from $3.6 million in 2003.
Wong has held senior management positions in the manufacturing, engineering and automotive industries.
Scientists uncover how cancer cells hide from immune system
By targeting the RNA helicase known as DDX6, scientists could enable the immune system to...
Vanillin flavouring in vapes may disrupt embryo development
Vanillin — a common flavouring chemical in e-cigarettes — may disrupt the normal...
Heart valve tissues created from stem cells
The breakthrough should help advance our understanding into how human heart valves develop,...
